Intimation of Credit Rating under Regulation 30 read along with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015.

METAL COATINGS (INDIA) LTD. W Regd. Office: 912, Hemkunt Chambers, 89, Nehru Place, New Delhi - 110 019 (India) @ c— CIN: L74899DL1994PLC063387 Phone: 011-41808125 il ‘Website: www.mcil.net E-mail: info@mcilindia.net 'ANTS0 SODEZ0TS CERTIFIED CONPARY Date: 07" November, 2026 BSE Limited Phireze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Sub.: Intimation of Credit Rating under Regulation 30 read along with Para A of Part A of Schedule IIT of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref.: Scrip Code - 531810; Scrip Id -METALCO; ISIN - INE161E01014 Dear Sir/Ma’am, Pursuant to Regulation 30 read along with Para A of Part A of Schedule IIT of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we would like to inform you that “Acuite Ratings & Research Limited”, the credit rating agency, vide its letter dated 06™ November, 2026, has reaffirmed the long term as well as short term credit ratings for the Company. The copy of the above said letter is attached herewith. Kindly take the information on record. Thanking you. For Metal Coatings (India) Limited Shimpy Goyal Company Secretary & Compliance Officer Rating Letter - Intimation of Rating Action Scan this QR Code to verify authenticity of this Letter Issued on : November 06, 2026 rating Letter Expires on : October 27, 2027 Annual Fee valid till : October 27, 2027 METAL COATINGS (INDIA) LIMITED 113, HSIIDC, INDUSTRIAL AREA ESTATE, SECTOR-59, Faridabad 121004 HARYANA Kind Attn.: R A Sharma,DGM Finance (Tel. No.9899759632) Sir / Madam, Sub.: Rating(s) Reaffirmed - Bank Loans of METAL COATINGS (INDIA) LIMITED Please note that the current rating(s) and outlook, instrument details, and latest rating action for the aforementioned instrument are as under: Product Quantum (Rs. Cr) Long Term Rating Short Term Rating Regulated By (Other FSR) Bank Loan Ratings 10.00 ACUITE BBB | - RBI Stable | Reaffirmed Bank Loan Ratings 5.00 - ACUITE A3+ | RBI Reaffirmed Total Outstanding 15.00 - - - Quantum (Rs. Cr) (cid:49)(cid:82)(cid:87)(cid:72)(cid:29)(cid:172)(cid:3)(cid:41)(cid:82)(cid:85)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:76)(cid:81)(cid:86)(cid:87)(cid:85)(cid:88)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:73)(cid:68)(cid:79)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:88)(cid:85)(cid:89)(cid:76)(cid:72)(cid:90)(cid:3)(cid:82)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:3)(cid:53)(cid:72)(cid:74)(cid:88)(cid:79)(cid:68)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:81)(cid:3)(cid:54)(cid:40)(cid:37)(cid:44)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3) grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available. (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112) reserves the right to revise the rating(s) , along with the outlook, at any time, on the basis of new information, or other circumstances which (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112)(cid:3)believes may have an impact on the rating (s). Such revisions, if any, would be appropriately disseminated by (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112)(cid:3)as required under prevailing SEBI guidelines and (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112)(cid:183)s policies. This letter will expire on October 27, 2027 or on the day when (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112)(cid:3)takes the next rating action, whichever is earlier. It may be noted that the rating(s) is subject to change anytime even before the expiry date of this letter. Hence lenders / investors are advised to visit https://www.acuite.in/ OR scan the QR code given above to confirm the current outstanding rating(s). (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112) will re-issue this rating letter on October 28, 2027 subject to receipt of surveillance fee as applicable. If the rating(s) is reviewed before October 27, 2027, (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112)(cid:3)will issue a new rating letter. Please note that under extant SEBI regulations and as per the terms of the rating agreement, once a rating is accepted and outstanding, the issuer is required to promptly furnish the (cid:182)No Default Statement(cid:183)(cid:3)on the first working day of every month. Sd/- Chief Rating Officer (cid:172) This is a system generated document. No signature is required. (cid:36)(cid:70)(cid:88)(cid:76)(cid:87)(cid:112)(cid:3)(cid:53)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:9)(cid:3)(cid:53)(cid:72)(cid:86)(cid:72)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:47)(cid:76)(cid:80)(cid:76)(cid:87)(cid:72)(cid:71) SEBI Registered | RBI Accredited 708, Lodha Supremus, Lodha iThink Techno Campus, Kanjurmarg (East), Mumbai - 400042 | +919930708000 | www.acuite.in | CIN: U74999MH2005PLC155683 (cid:36)(cid:81)(cid:81)(cid:72)(cid:91)(cid:88)(cid:85)(cid:72)(cid:86)(cid:29)(cid:3)(cid:172)(cid:172)(cid:172)(cid:172)(cid:172)(cid:172)(cid:172)(cid:172)(cid:172)(cid:3)(cid:3)(cid:3)(cid:36)(cid:17)(cid:3)(cid:39)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:53)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:44)(cid:81)(cid:86)(cid:87)(cid:85)(cid:88)(cid:80)(cid:72)(cid:81)(cid:87) Annexure A. Details of the rated instrument Lender's Name Facilities Listing status Regulated Scale Amt. Rating Assigned By (Rs. Cr) (Outlook) | Rating Action HSBC Limited Secured Unlisted RBI Long- 10.00 ACUITE BBB | Overdraft term Stable | Reaffirmed Not Applicable Proposed Unlisted RBI Short- 4.00 ACUITE A3+ | Short Term term Reaffirmed Bank Facility Not Applicable Proposed Unlisted RBI Short- 1.00 ACUITE A3+ | Short Term term Reaffirmed Bank Facility Total Facilities 15.00 - (cid:49)(cid:82)(cid:87)(cid:72)(cid:29)(cid:172)(cid:3)(cid:41)(cid:82)(cid:85)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:76)(cid:81)(cid:86)(cid:87)(cid:85)(cid:88)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:73)(cid:68)(cid:79)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:88)(cid:85)(cid:89)(cid:76)(cid:72)(cid:90)(cid:3)(cid:82)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:3)(cid:53)(cid:72)(cid:74)(cid:88)(cid:79)(cid:68)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:81)(cid:3)(cid:54)(cid:40)(cid:37)(cid:44)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3) grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available. List of instruments and names of regulators of the instruments As required by SEBI Circular (SEBI/HO/DDHS/DDHS-PoD-2/I/4685/2026) dated February 10, 2026, a list of activities or instruments falling under the purview of various Financial Sector Regulators (FSRs), along with the names of respective FSRs, is being disclosed below: A. Rating Activity Sr. No. Instrument / activity Name Regulator of the instrument 1 Listed/Proposed to be listed Bonds/Debentures/Preference Shares (all SEBI securities) 2 Unlisted/Proposed to be unlisted Bonds/Debentures/ Preference share MCA (all securities) 3 Listed PTCs / Securitisation Notes (originated by entities regulated by RBI) RBI (cid:241)(cid:3)(cid:4204)(cid:3) 4 Listed PTCs / Securitisati [Showing first 8,000 characters — download PDF for full document]